Anticoagulation Management Post Pulmonary Embolism.
Methodist Debakey Cardiovasc J
; 20(3): 27-35, 2024.
Article
em En
| MEDLINE
| ID: mdl-38765210
ABSTRACT
Pulmonary embolus (PE) carries a significant impending morbidity and mortality, especially in intermediate and high-risk patients, and the choice of initial anticoagulation that allows for therapeutic adjustment or manipulation is important. The preferred choice of anticoagulation management includes direct oral anticoagulants. Vitamin K antagonists and low-molecular-weight heparin are preferred in special populations or selected patients such as breastfeeding mothers, those with end-stage renal disease, or obese patients, among others. This article reviews the primary and longer-term considerations for anticoagulation management in patients with PE and highlights special patient populations and risk factor considerations.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Embolia Pulmonar
/
Anticoagulantes
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article